Stem Cell Treatment is a method of transplanting healthy stem cells into a patient to repair or replace damaged cells or tissues, thereby achieving the goal of healing. Stem cell transplantation has a wide range of treatments, and can generally treat neurological diseases, immune system diseases, and other medical and surgical diseases.
This report contains market size and forecasts of Stem Cell Treatments in Global, including the following market information:
Global Stem Cell Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stem Cell Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adipose Tissue-Derived Mesenchymal Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stem Cell Treatments include Osiris Therapeutics, Inc, MEDIPOST Co., Ltd, JCR Pharmaceuticals Co., Ltd, FUJIFILM Cellular Dynamics, Inc., Holostem Terapie Avanzate S.r.l., Athersys Inc., CORESTEM, Inc, Mesoblast Ltd. and Regenexx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stem Cell Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stem Cell Treatments Market Segment Percentages, by Type, 2021 (%)
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Other Cell Sources
Global Stem Cell Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stem Cell Treatments Market Segment Percentages, by Application, 2021 (%)
Nerve Diseases
Immunological Diseases
Musculoskeletal Disorders
Cardiovascular Diseases
Gastrointestinal Diseases
Other
Global Stem Cell Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stem Cell Treatments Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Treatments revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Stem Cell Treatments revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Osiris Therapeutics, Inc
MEDIPOST Co., Ltd
JCR Pharmaceuticals Co., Ltd
FUJIFILM Cellular Dynamics, Inc.
Holostem Terapie Avanzate S.r.l.
Athersys Inc.
CORESTEM, Inc
Mesoblast Ltd.
Regenexx
Reliance Life Sciences Private Limited
U.S. Stem Cell, Inc.
Vericel Corporation
Pharmicell Co., Ltd